News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,285 Results
Type
Article (85689)
Company Profile (747)
Press Release (746849)
Section
Business (232289)
Career Advice (4108)
Deals (39652)
Drug Delivery (119)
Drug Development (90702)
Employer Resources (194)
FDA (17988)
Job Trends (17275)
News (395664)
Policy (39630)
Tag
Academia (2975)
Alliances (56515)
Alzheimer's disease (1356)
Approvals (17897)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12549)
Biotechnology (512)
Breast cancer (173)
Cancer (1374)
Cardiovascular disease (120)
Career advice (3514)
Cell therapy (306)
Clinical research (71847)
Collaboration (479)
Compensation (253)
COVID-19 (2810)
C-suite (119)
Data (1377)
Diabetes (177)
Diagnostics (6709)
Earnings (94798)
Employer resources (167)
Events (127244)
Executive appointments (371)
FDA (18642)
Funding (428)
Gene therapy (219)
GLP-1 (710)
Government (5052)
Healthcare (20735)
Infectious disease (2907)
Inflammatory bowel disease (124)
Interviews (807)
IPO (17616)
Job creations (5180)
Job search strategy (2855)
Layoffs (492)
Legal (10048)
Lung cancer (204)
Manufacturing (222)
Medical device (14446)
Medtech (14451)
Mergers & acquisitions (22125)
Metabolic disorders (498)
Neuroscience (1702)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1664)
Obesity (287)
Opinion (245)
Patents (123)
People (64292)
Pharmaceutical (152)
Phase I (22128)
Phase II (31199)
Phase III (23520)
Pipeline (511)
Postmarket research (3546)
Preclinical (10000)
Radiopharmaceuticals (259)
Rare diseases (276)
Real estate (7373)
Regulatory (26060)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1457)
Startups (4276)
United States (15739)
Vaccines (663)
Weight loss (228)
Date
Today (153)
Last 7 days (682)
Last 30 days (3145)
Last 365 days (38343)
2024 (36951)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (229)
Asia (49445)
Australia (8711)
California (3853)
Canada (1404)
China (303)
Colorado (176)
Connecticut (189)
Europe (113240)
Florida (519)
Georgia (138)
Illinois (444)
Indiana (234)
Maryland (667)
Massachusetts (3095)
Michigan (187)
Minnesota (309)
New Jersey (1102)
New York (1081)
North Carolina (870)
Northern California (1664)
Ohio (154)
Pennsylvania (919)
South America (1647)
Southern California (1457)
Texas (566)
Utah (110)
Washington State (424)
There are 833,285 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific with Promising Breast Cancer Data
BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech obtained the candidate when it bought Biotheus last month in an acquisition deal that could reach up to $950 million.
December 11, 2024
·
2 min read
·
Tristan Manalac
RSV
Moderna’s RSV Vaccines Run into Safety Roadblock
The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines.
December 11, 2024
·
2 min read
·
Tristan Manalac
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment model; Eli Lilly and Novo Nordisk pump new funds into manufacturing; and AbbVie makes a Cerevel comeback while uniQure clears a path toward accelerated approval in Huntington’s disease.
December 11, 2024
·
1 min read
·
Heather McKenzie
Press Releases
Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer
December 11, 2024
·
5 min read
Press Releases
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
December 11, 2024
·
3 min read
Press Releases
Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer
December 11, 2024
·
7 min read
Press Releases
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET
December 11, 2024
·
9 min read
Press Releases
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy
December 11, 2024
·
8 min read
Press Releases
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
December 11, 2024
·
9 min read
Press Releases
Leapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research
December 11, 2024
·
3 min read
1 of 83,329
Next
